HWBK vs RARE · P/E 10, rev $48.7M vs rev $350.0M
Hawthorn Bancshares Inc (HWBK) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Hawthorn Bancshares Inc (HWBK) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported HWBK revenue for 2026-06-30 was $48.7M. Net income was $13.1M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. HWBK currently screens at market cap $251.1M and trailing P/E 10.4.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
HWBK currently screens at market cap $251.1M and trailing P/E 10.4. RARE currently screens at market cap $2.79B.
Not investment advice. Open the HWBK and RARE stock pages for the full models.
Not investment advice.